TY - GEN
T1 - Sub-second measurements of glutamate and other neurotransmitter signaling using enzyme-based ceramic microelectrode arrays
AU - Hascup, Erin R.
AU - Hascup, Kevin N.
AU - Talauliker, Pooja M.
AU - Price, David A.
AU - Pomerleau, Francois
AU - Quintero, Jorge E.
AU - Huettl, Peter
AU - Gratton, Alain
AU - Strömberg, Ingrid
AU - Gerhardt, Greg A.
PY - 2013
Y1 - 2013
N2 - We have set out to develop a novel, implantable microelectrode array that has the capabilities to detect neurotransmitters with enhanced sensitivity, selectivity, and temporal sampling capabilities compared to other current technologies. We have shown that this device maintains recording performance during chronic measurements of extracellular neurotransmitter levels for at least 7 days postimplantation, single-unit neuronal activity for as long as 6 months, and provides enhanced biocompatibility compared to current technologies. As we continue to refine and improve our recording capability, we are able to incorporate the chronic microelectrode array technology into multimodal experimental paradigms, such as behavioral testing, pharmacological intervention (local and systemic), or combined measurements of neurotransmitter levels and neuronal activity (local field potential). Furthermore, the improvements made with the microelectrode technology discussed in this chapter have the potential to conduct longitudinal analyses that can benefit a wide range of translational efforts, including studies on learning and memory, aging, neurodegenerative disease progression, and traumatic brain injury neuropathology.
AB - We have set out to develop a novel, implantable microelectrode array that has the capabilities to detect neurotransmitters with enhanced sensitivity, selectivity, and temporal sampling capabilities compared to other current technologies. We have shown that this device maintains recording performance during chronic measurements of extracellular neurotransmitter levels for at least 7 days postimplantation, single-unit neuronal activity for as long as 6 months, and provides enhanced biocompatibility compared to current technologies. As we continue to refine and improve our recording capability, we are able to incorporate the chronic microelectrode array technology into multimodal experimental paradigms, such as behavioral testing, pharmacological intervention (local and systemic), or combined measurements of neurotransmitter levels and neuronal activity (local field potential). Furthermore, the improvements made with the microelectrode technology discussed in this chapter have the potential to conduct longitudinal analyses that can benefit a wide range of translational efforts, including studies on learning and memory, aging, neurodegenerative disease progression, and traumatic brain injury neuropathology.
KW - Behavior
KW - Biosensor
KW - Chronic
KW - Glutamate
KW - Histology
KW - Neurochemistry
UR - http://www.scopus.com/inward/record.url?scp=84877276678&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84877276678&partnerID=8YFLogxK
U2 - 10.1007/978-1-62703-370-1_8
DO - 10.1007/978-1-62703-370-1_8
M3 - Conference contribution
AN - SCOPUS:84877276678
SN - 9781627033695
T3 - Neuromethods
SP - 179
EP - 199
BT - Microelectrode Biosensors
ER -